DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Barenholz Y.
Doxil®–the first FDA-approved nano-drug: lessons learned.
J Control Release 2012;
160 (02) 117-134
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.